Economic Evaluation of Smoking-Cessation Therapies
- 266 Downloads
Smoking is probably the most important among preventable health risks. Health economic evaluation of smoking-cessation interventions, applying a lifetime perspective, is made possible by available epidemiological knowledge. The well established method of performing cost-effectiveness analyses of smoking-cessation interventions involves mathematical modelling (both deterministic and stochastic) of future events important for cost effectiveness.
This study surveys cost-effectiveness analyses of smoking cessation, with a particular focus on the mathematical modelling and simulation analyses performed.
A systematic literature search was performed using the databases MEDLINE, Econlit and Academic Search Complete.
Health economic evaluations, published as full-length journal articles, were searched for.
423 studies were identified and 78 were finally included, of which 30 were assessed as being highly relevant, based on the application of simulation modelling.
In general, studies are well performed as regards modelling. Common weaknesses include reporting of modelling details; validation of used simulation models; and the handling of structural uncertainty and different types of heterogeneity.
KeywordsSmoking Cessation Sickness Absenteeism Nicotine Replacement Therapy Varenicline Health Economic Evaluation
No sources of funding were used to prepare this article. The author has no conflicts of interest that are directly relevant to its content and the opinions expressed are the author’s own.
- 6.Royal College of Physicians. Smoking and health: summary and report of the Royal College of Physicians of London on smoking in relation to cancer of the lung and other diseases. New York: Pitman Publishing, 1962Google Scholar
- 7.U.S. Department of Health, Education, and Welfare. Smoking and health: report to the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: U.S. Government Printing Office, 1964. PHS publication no.: 1103Google Scholar
- 8.World Health Organization. Tobacco or health: a global status report. Geneva: WHO, 1997Google Scholar
- 10.Shafey O, Dolwick S, Guindon GE, editors. Tobacco control country profiles. 2nd rev. ed. Atlanta (GA): American Cancer Society, 2003Google Scholar
- 25.Hoogenveen RT, de Hollander AEM, van Genugten MLL. The chronic disease modeling approach. Bilthoven: National Institute of Public Health and the Environment (RIVM), 1998Google Scholar
- 27.Prevent [computer program]. Version 3.01. Wilston (QLD): EpiGear International, 2009 [online]. Available from URL: http://www.epigear.com/index_files/prevent.html [Accessed 2011 Feb 5]
- 42.Parrott S, Godfrey C, Raw M, et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions: health educational authority. Thorax 1998; 53 Suppl. 5: 1–38Google Scholar
- 66.Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press, 2006Google Scholar